Laman UtamaKHTRF • OTCMKTS
add
Knight Therapeutics Inc
Tutup sebelumnya
$4.46
Julat tahun
$3.48 - $4.55
Permodalan pasaran
605.64J CAD
Bilangan Purata
2.90K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
TSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(CAD) | Dis 2024info | Perubahan T/T |
---|---|---|
Hasil | 96.86J | 30.55% |
Perbelanjaan pengendalian | 43.31J | 26.28% |
Pendapatan bersih | 10.74J | 144.13% |
Margin untung bersih | 11.08 | 133.79% |
Pendapatan bagi setiap syer | 0.11 | 175.39% |
EBITDA | 6.46J | -17.88% |
Kadar cukai berkesan | -36.32% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(CAD) | Dis 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 172.84J | 1.75% |
Jumlah aset | 963.80J | 1.94% |
Jumlah liabiliti | 168.69J | -15.07% |
Jumlah ekuiti | 795.10J | — |
Syer tertunggak | 100.05J | — |
Harga kepada buku | 0.56 | — |
Pulangan pada aset | -0.77% | — |
Pulangan pada modal | -0.88% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(CAD) | Dis 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 10.74J | 144.13% |
Tunai daripada operasi | 1.47J | -91.81% |
Tunai daripada pelaburan | 18.05J | 1,049.45% |
Tunai daripada pembiayaan | -15.35J | 56.99% |
Perubahan bersih dalam tunai | 6.35J | 134.04% |
Aliran tunai bebas | 4.96J | -91.80% |
Perihal
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Diasaskan
2014
Ibu pejabat
Tapak web
Pekerja
745